Ebix's Health-Tech Overhaul: AI, New Leadership, and a Mandate for Growth

JOHNS CREEK, Ga. – July 21, 2026 – In a strategic move signaling a major push to revitalize its health-tech assets, global fintech and insurance marketplace provider Ebix has appointed Mary Beth Titsworth as Vice President for its Health and Wellness vertical. Titsworth, a seasoned healthcare transformation executive, is tasked with spearheading an ambitious growth strategy for the company's long-standing medical content brands, Oakstone and A.D.A.M., blending advanced AI with new, innovative product offerings.

The appointment is the centerpiece of a broader initiative by Ebix to modernize its health content division, aiming to enhance operational efficiency and unlock new revenue streams. By leveraging artificial intelligence and launching novel concepts like 'CMEescape'—a program combining accredited medical education with curated travel—Ebix is betting it can transform its trusted, yet traditional, content libraries into dynamic, high-growth assets for the modern healthcare market.

A Mandate for Growth Amidst Corporate Headwinds

The strategic pivot in the Health and Wellness vertical comes at a critical time for Ebix. While the company has reported strong performance in certain divisions, such as its EbixCash payment solutions and its record-breaking Annuity Exchange, it has also navigated significant corporate challenges. In 2021, the abrupt resignation of its auditor over “significant unusual transactions” and identified material weaknesses in internal controls triggered a sharp decline in its stock price and a series of securities fraud lawsuits, eroding investor confidence. Ebix's stock has lost a substantial portion of its value since late 2020.

Against this backdrop, the move to aggressively scale the health vertical appears to be a calculated effort to diversify growth drivers and demonstrate forward-looking innovation. Titsworth's mandate is explicitly commercial. She will lead content strategy, product direction, and go-to-market execution to expand the company's footprint across healthcare providers, health systems, academic institutions, and payers. Her background includes modernizing legacy businesses and building a multimillion-dollar healthcare consulting operation from the ground up, experience that aligns directly with Ebix's stated goals.

"Oakstone and A.D.A.M. are trusted brands for clinical content and healthcare education," said Gagan Sethi, Chief Executive Officer of Ebix Technologies, in the official announcement. "That is a very strong foundation to build from. Mary Beth brings the commercial experience, healthcare market understanding, and execution focus needed to help us expand these assets into new revenue opportunities."

Sethi's emphasis on preserving clinical rigor while using AI and automation to improve the operating model underscores the dual objectives of the strategy: protect the core value of the brands while aggressively pursuing modernization and profitability.

The AI Arms Race in Medical Content

At the heart of Ebix's transformation strategy is the integration of artificial intelligence. The company is entering a fiercely competitive arena where technology giants are already deploying sophisticated AI tools. Competitors like WebMD's Medscape and Wolters Kluwer's UpToDate have recently launched their own generative AI platforms, Medscape AI and UpToDate Expert AI, respectively. These tools are built on proprietary, clinically vetted content, designed to provide physicians with fast, evidence-based answers while minimizing the risk of AI "hallucinations"—inaccurate or fabricated information—that plague open-internet models.

Ebix is positioning its strategy not just as an internal efficiency play but as a B2B solution for the entire healthcare AI ecosystem. Through its EbixONE AI initiative, the company has launched a "Verified Medical Data Platform." This platform licenses the trusted, evidence-based content from A.D.A.M.'s extensive patient education library and Oakstone's deep well of continuing medical education (CME) materials. The goal is to provide a "clinically safe" and reliable foundation for hospitals, universities, and other AI firms to train their own machine learning models. By offering governed, medically reviewed data, Ebix aims to solve one of the biggest challenges in healthcare AI: sourcing high-quality, unbiased training data.

This approach allows Ebix to monetize its decades-old content archives in a new way, positioning itself as a critical infrastructure provider in the burgeoning medical AI market. The success of this strategy will depend on its ability to convince the market that its data provides a superior, safer alternative for developing the next generation of clinical decision support and patient engagement tools.

Balancing Trust with Transformation

For brands like Oakstone, with 50 years of history in continuing medical education, and A.D.A.M., with over 25 years providing health information, trust is their most valuable currency. The central challenge for Titsworth and her team will be to infuse technology and automation into content development and delivery without compromising the clinical credibility that physicians and patients rely on.

"Clinicians and healthcare organizations have trusted Oakstone and A.D.A.M. for decades because the content is credible and built with care," Titsworth stated. "My focus will be to protect that foundation while expanding how we serve providers, healthcare organizations, partners, and patients through stronger strategic partnerships."

This balance is crucial. The ethical implications of AI in medicine are profound, touching on issues of accuracy, data bias, transparency, and accountability. By creating a closed-system AI training platform based on its own expert-validated content, Ebix is attempting to address these concerns head-on. However, maintaining human oversight and ensuring that physician-led quality control remains the final arbiter of content accuracy will be paramount to retaining the trust of the medical community.

Redefining Medical Education with 'CMEescape'

Beyond its deep-tech AI strategy, Ebix is also innovating on the product front with the launch of 'CMEescape'. This new concept taps into the growing 'bleisure' trend by pairing accredited medical education with curated, luxury travel experiences, from rail journeys across Europe to tours in India. The global CME market, valued at over $10 billion, is increasingly shifting toward flexible, digital-first formats, but there remains a strong appetite for engaging, in-person, and hybrid experiences.

'CMEescape' aims to capture this segment by offering AMA PRA Category 1 CME credits in a format that combines professional development with leisure. While the concept of "travel CME" is not new, Ebix's execution—partnering its established Oakstone CME brand with high-end travel packages—is a compelling proposition. Its success will hinge on seamless execution, from securing and documenting proper accreditation to ensuring the educational components are robust and independent of any marketing influence, in line with standards from bodies like the Accreditation Council for Continuing Medical Education (ACCME).

This initiative represents a tangible example of how Ebix plans to find new commercial applications for its existing assets, moving beyond traditional online courses to create premium, experience-based educational products for a discerning professional audience.